CSIR-NCL Hosts Prof. K. Venkataraman Memorial by Dr. Mukund Gurjar

Dr. Mukund Gurjar shared experiences of collaborations with pharmaceutical companies and breakthroughs in Active Pharmaceutical Ingredient (API) development.
Dr. Mukund Gurjar
Dr. Mukund GurjarThe Bridge Chronicle
Published on

Pune: The CSIR-National Chemical Laboratory (CSIR-NCL) in Pune hosted the prestigious Prof. K. Venkataraman Memorial Lecture on September 19, 2024.

The featured speaker, Dr. Mukund K. Gurjar, Chief Scientific Officer and member of the Board of Directors at Emcure Pharmaceuticals Limited, captivated the audience with an insightful lecture titled “My Science Journey and Where I Am Now.”

Dr. Gurjar recounted his early fascination with science, beginning with his research work at Nagpur University and continuing through his academic tenure at the University of London.

Dr. Mukund Gurjar
CSIR-NCL and Danish Patent Office Collaborate on Biotech and Medtech Patent Issues

He discussed his pivotal Ph.D. work, particularly his mechanistic studies on the Stobbe reaction, and explained his discovery of the rapid formation of the 3',6'-Anhydro ring compared to the 1,2-anhydro ring, driven by the influence of neopentyl CH2OH. His insights shed light on the structural dynamics of the furanose ring.

Dr. Gurjar’s presentation spanned a wide array of his scientific contributions, including oligosaccharide synthesis, understanding N-glycan biosynthetic pathways, and the synthesis of cell wall arabinogalactan peptidoglycans in Mycobacterium tuberculosis.

He emphasized the practical applications of these discoveries in the pharmaceutical industry, particularly his pioneering work on AZT and its subsequent industrial manufacturing applications.

Dr. Mukund Gurjar
Maharashtra to Host 'Startup Week' to Boost Innovative Startups

Dr. Gurjar shared experiences of his collaborations with leading pharmaceutical companies and discussed notable breakthroughs in Active Pharmaceutical Ingredient (API) development, citing key products such as S-Amlodipine, S-Metoprolol, S-Atenolol, and Eribulin.

His lecture also explored the vital relationship between academic research and industrial application, particularly in the synthesis of peptides, Gd-chelating agents, and the role of chirality in pharmaceutical development. He highlighted how chiral switching has shaped the modern pharmaceutical industry.

Dr. Ashish Lele, Director of CSIR-NCL, praised Dr. Gurjar’s remarkable contributions to Organic Chemistry and noted that luminaries like him would continue to inspire future scientific exploration at CSIR-NCL. The event was anchored by Dr. Swati Chadha, with Dr. Moneesha Fernandes delivering vote of thanks.

Enjoyed reading The Bridge Chronicle?
Your support motivates us to do better. Follow us on Facebook, Instagram and Twitter to stay updated with the latest stories.
You can also read on the go with our Android and iOS mobile app.

Related Stories

No stories found.
logo
The Bridge Chronicle
www.thebridgechronicle.com